Dr. Amidon joined the University of Michigan, College of Pharmacy as Research Professor of Pharmaceutical Sciences in 2007 after 28 years in the pharmaceutical industry. Prior to joining the University of Michigan, Dr. Amidon held research positions in pharmaceutical R&D for Pfizer, Pharmacia, Pharmacia & Upjohn, and The Upjohn Company. He is recognized for his expertise in the physical, chemical, and mechanical property characterization of active pharmaceutical ingredients, excipients, and products as well as the development of scientific strategies for oral solid dosage form development. His current research interests focus on oral bioperformance assessment and in vivo predictive dissolution.
He received his Bachelor of Science degree in Medicinal Chemistry (1974) and his Ph.D. in Pharmaceutical Chemistry (1979) from the University of Michigan at Ann Arbor, MI.
Dr. Amidon has served in a number of leadership roles in the American Association of Pharmaceutical Scientists (AAPS) as well as the United States Pharmacopeia (USP). He is a member, Fellow, and past President of AAPS. He is the recipient of the 2014 AAPS Research Achievement Award in Physical Pharmacy and Biopharmaceutics as well as the 1983 Ebert Prize from the American Pharmacists Association. He has served as a member and chair of several USP Expert Committees and Expert Panels and is currently a member of the USP Board of Trustees representing pharmaceutical sciences where he currently chairs the Board’s Operations Committee.